Jamie Dananberg, Chief Medical Officer at Unity Biotechnology, Inc. (UBX), sold 420 shares at $1.70 ($714) on 2023-03-31, disclosed to the SEC on 2023-04-03.
Scheduled sale ($714) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANNX | SELL | 2025-02-20 | $16K | — | Filing → |
| UBX | SELL | 2023-03-15 | $4K | — | Filing → |
| UBX | SELL | 2023-02-03 | $4K | — | Filing → |